Solving Drug Shortages One Medicine at a Time

In this episode of the Driving the Business of Science podcast, host Keith Parent, CEO of Court Square Group, discusses the challenges of drug development and shortages with Sarah Norring, Ph.D., Co‑founder and CEO of Plenitude Pharma Inc. Sarah highlights the critical need to address drug shortages and discontinuations, emphasizing the importance of having multiple manufacturers for essential medicines. She shares her background in medical science and her company's focus on bringing back critical drugs, particularly in women's health and oncology. Sarah mentions the FDA's expedited review process for off-patent drugs on the FDA’s drug shortage list, and her aims to bring one to two products to market within the first three years. The conversation also touches on the challenges of fundraising in this niche pharma sector.Driving the Business of Science is the podcast for clinical operations, IT, and business managers in the pharma, biotech, and medical device world.Bringing new products to market takes more than just great science. From R&D and clinical to regulatory and approval life science leaders require fit-for-purpose technology, processes, and partners at step.In the Driving the Business of Science podcast leaders from across the life science industry share real-world experiences and practical insights that will impact your business.Join host Keith Parent, serial life science CEO, as business leaders share experiences and insights on emerging challenges in the life science market.